Argent Biopharma (AU:RGT) has released an update.
Argent Biopharma Limited has announced the application for quotation of 625,000 newly issued securities on the ASX, under the code RGT. The securities are ordinary fully paid shares and are part of a transaction previously communicated in an Appendix 3B. This move indicates Argent Biopharma’s efforts to increase its financial activities and presence in the stock market as of July 3, 2024.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.
